{"ticker": {"uuid": "bf454d1c-3543-4349-b9de-30325c7f0473", "symbol": "NXL", "name": "Nexalin Technology Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance Level - ATR Stop", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNNktBdW1SWTg4WVpCZmNMUWxoVmxDajU5YTg0bWhRRTFEU3MyYmxUcXc1SThWel9MNGpETE9mLXg4MkF6WGkycHFDZGY0d1Y1UzZsRUdMUU54ajd5ZjZlQmlnc0p0Yl9GSkJtdkUyR3o0alktclp0bVpGMzJ6UnBjRnVkaUc2QmRLV2tIM1M3ZjZtb1otZ0hoWjBfWWlUY0RSTWdGR0ctbnVuNXFMbUhuMllXRW5NZw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T18:47:47+00:00", "published_display": "14 Jul 2026 18:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nexalin Technology (NXL) plans new 7M-share incentive pool and reverse split authority", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVDVBSzRieHhQUng4Z0syV0xTTmpTRWlpNU5qTGRzRG5DaXNyLW1qb3o2UDBMMERtOVJwSFIxSWtDa0xqcmtndS1zOGRYX0I4NGhqazg1cDd1b2NHTzFWQ2JMQXRpamk3Yk4weENTajF0V3hYZEQyNTRqcmZKZW81TWFQX2VfcjRuNGZQbjRaeFZmQWVXaHhBM0R6TGVTcUxXT1oxLVRTcjVrS3UzdTdvMXpPREZsb1RKNkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:30:34+00:00", "published_display": "10 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage Continues", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOXzFwRVlWUHRyNFRTQWdDZ0EwQ1RaNHNVU2NJdFhxWDg0TmJ2VkV4cmJVVHRIQm9fX244VDAza2xxeXNkZ2ZGOVA0V0h3S2k4aTFJX0lzbDYtMy1DWlRYM3dBdEctM2VUTk9obkdSMzRpRGdpR2wtZDcxS0pNX0RpQ0Y2dzgtQlhCYmg4dWVUMmtaUG5XYXh4SDBGOWhYQVYxRVRVS2NJbWh5MlJqMDJYX1JUUG0tZldCd0tRTXZXX3dJYzkxNzhBbzFBSm9nV1JOM3d3Wl9jYw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-07T23:30:05+00:00", "published_display": "07 Jul 2026 23:30", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Nexalin Technology, Inc. \u2013 NASDAQ:NXL", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPenpranR3cWdyOFhQVkNhaUhrcnVzSjg4Tkp2NlAzcE5vdExqNk9PVW1SMVg5endoTzJCMkRyX2VhOFlfYnh1RWJ0MV9pMzdrd0w2TW50VGlVcENzMmFCWEVYN3JGZ3N3Z1BEMGthWWNNS29QTERJRUhHaUVHbHZXMl81Zjg5U21zb3ZtNFBMTUNKX2tvYzRnZXNqYw?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T11:32:53+00:00", "published_display": "05 Jul 2026 11:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company\u2019s Proprietary DIFS\u2122 Platform", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nexalin-technology-announces-investigator-brazilian-123000212.html", "source_name": "GlobeNewswire", "published_at": "2026-06-23T12:30:00+00:00", "published_display": "23 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Brazil sleep trial earns award at brain congress", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNjVkaEhvdVpDT0dLNFRRYmMtbXNmNVFzblVIc0hkRGZodWN2Ny1mMGNGLVFDSnhMb2V2RkI0VTZKU09pZE9NRHlpRHJuLVE1U0o0bjZDVDF3aldWaF9MeXdtSnVfZFdLWlhiang4VmFRVWVtMkhFUl85TGZDWG5jOTBKYWwtWEdmc0o4YmdOUmNFN1doQjJMSkV2Y05PWXZHUHJTTS1Lb3FjeEY5LThrUGhOM3J2WjFyeWQxeVZB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology, Inc. Financial Disclosures & SEC Filings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE5aWlFjTF9DMXFsc29weVZDWWxHLU95TElxbVFpTmhGemc4MXhRbE11SUEwSVpILUs2TjdNZm9hcGJCMm5wZ2tZLTVnLXNLZjNadWw0WWxfTnc3Znh2T0FhQkFlQzlUNnVv?oc=5", "source_name": "TradingView", "published_at": "2026-06-21T06:39:02+00:00", "published_display": "21 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology (NXL) overhauls bylaws, lowers quorum and adds exclusive forum rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNLUc2RVo5TnRyZk5rbTFwOHZCelpkMFhzSXZ0YjhxcXptWnNLTWtNdzUtRXJCTWNOMktfXy03U3dRRFpjSWJZaVdkMVg3eHBKSF9tWnJ2MmhXVGdkRUczNzQzNnhHblo5WmhZY1JfdjVPMjQ0WWJxMnh0R3lBMWJXcDFKZFlLOGZQWXA4NjFhUEk1R3o2YURXeTVoU1Bmb2oxSzNlbm5HWVlNZXF1RXIw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nexalin-technology-announces-two-clinical-131500210.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T13:15:00+00:00", "published_display": "16 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-study-shows-strong-anxiety-134705543.html", "source_name": "MT Newswires", "published_at": "2026-06-10T13:47:05+00:00", "published_display": "10 Jun 2026 13:47", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-reports-compelling-clinical-131500924.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T13:15:00+00:00", "published_display": "10 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/exclusive-nexalin-brazil-trial-shows-130109302.html", "source_name": "Benzinga", "published_at": "2026-06-10T13:01:09+00:00", "published_display": "10 Jun 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-announces-issuance-u-140000209.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T14:00:00+00:00", "published_display": "04 Jun 2026 14:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-secures-key-neurostimulation-123000111.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T12:30:00+00:00", "published_display": "21 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nexalin Acquires PONM to Expand AI Health Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNUjdsUUp5TTU2NFprUi1MbEljRlhNLUZfVHNUMTJubzA4WjRiRlNnaTJDTmRZVzRpZk5GRjVrZXIwWjJleGFQRGVmSThVUFE1OHRTREUzUXBMRl9ieG9mdGRzazNKNHNZVDVxOURrWmpjdnYtQVpQU0NFNWUzMHdscTJqR2dMWlBVcFZjbWRDbUFZYXFSU1FLU3RaSHhZc1g0cVRvbkRJbWgwOXNFWWtYd3F4LUpsUThHbE41Mkx3ai1BZ2E5N1ktR3J2UFdCQXY3X3c?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO\u2122 Clarity and Nexalin NeuroCare\u2122 Ahead of Planned FDA Pivotal Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-acquires-ai-integrated-digital-123000796.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Acquires PONM for $1.3 Million in Stock, Adds 24-Month GLV Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNRzJYMFUxWVhFc1lPMzdXTy1OU05YYjR5NVduWTBlMWZqN1h0SThKTHIwb3hrOEdPdFg4anVjanctalFMRXl2aUNyaUJ0Qy1xYmNCUkxNYXd0ODNRMDQ4MHZja0doVnVYWHd6Y3pIODlzMzdwcnRJZkpVQWRpQXRGR2Izc2FCUlZTUGY2dHVVTVRNdWozb0QyN1p2TXVpc1QtQ3lyRVNyLWlhazc0c0RPZVZLSlo0dFJ1UUxEVkJaVm14VUQxRGFPd0JybmhtQ0ZFbldMZlVOTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects  and Clinical Improvement in Chronic Insomnia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-announces-peer-reviewed-publication-131500841.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T13:15:00+00:00", "published_display": "28 Apr 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "After FDA and China meetings, Nexalin reshapes Alzheimer\u2019s study", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPV3hIaXpFbmlsSkcta0tmS2xKRFY1WE1sZTNfMDlUNnlZQklxNGN4Tl8xMGZfZXRTbEpkaDFsUFZFaDVrNWNSZEVMT2hwWWg0bWtxMXVZeklVei1nUTFMTktDdHZIaE91Nld2UGJULURiZVhhbVJxa05ibGRBaG12XzdLeU9ITFA1RUlvWmhDZGFrMzJwY0Y5UUpsS1lGZDlDUGdab1lhSUlYZmNjeVA3MWNxejA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Nexalin Technology stock rises after launching AI-powered virtual clinic", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPdHhrZ3RndjdPU3Y5OWFFQmNfUkZXNkNnT1BYaHRzaFQtT3NFcGRQeVRtUGtJZXZORkNNeHU5eElKM09tRW51NDd4dTRVZmJOYXFMVGJoLXc3VVJydXdCN1pCRE5yYi1tMGYtbVdoY2RNbTZrZFJiVUVOOEdodjVvVVRCU2UtbHFMUHBReWM0RVJGb0hDR0Q1Z01sN0U3dzJFVGQySFpnbUdVRUhrWDRNR2VLWlR4TGs5Wm5ma19PbGZoMjNOSnpwdkhOVGVVZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQR2dnMlhlVWJLZmFKQ0tTRFN2M01saktkUVNlcURYWEhwZldJRllLYVBPcWtKb09UaGVxZGROOXQ5cnhMd0FjcWxwM3J0SHR2LUFzbW9xQlA0b3pybVdxakFIcjljbWNuVTBJa1k1ZjlGdlJ5eXBKWFBGOXcwUlhPb1VhTzF5Vzg?oc=5", "source_name": "Market source", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance Level - ATR Stop", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNNktBdW1SWTg4WVpCZmNMUWxoVmxDajU5YTg0bWhRRTFEU3MyYmxUcXc1SThWel9MNGpETE9mLXg4MkF6WGkycHFDZGY0d1Y1UzZsRUdMUU54ajd5ZjZlQmlnc0p0Yl9GSkJtdkUyR3o0alktclp0bVpGMzJ6UnBjRnVkaUc2QmRLV2tIM1M3ZjZtb1otZ0hoWjBfWWlUY0RSTWdGR0ctbnVuNXFMbUhuMllXRW5NZw?oc=5", "source_name": "dars.gov.et", "published_at": "2026-07-14T18:47:47+00:00", "published_display": "14 Jul 2026 18:47", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology (NXL) plans new 7M-share incentive pool and reverse split authority", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxOVDVBSzRieHhQUng4Z0syV0xTTmpTRWlpNU5qTGRzRG5DaXNyLW1qb3o2UDBMMERtOVJwSFIxSWtDa0xqcmtndS1zOGRYX0I4NGhqazg1cDd1b2NHTzFWQ2JMQXRpamk3Yk4weENTajF0V3hYZEQyNTRqcmZKZW81TWFQX2VfcjRuNGZQbjRaeFZmQWVXaHhBM0R6TGVTcUxXT1oxLVRTcjVrS3UzdTdvMXpPREZsb1RKNkE?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T20:30:34+00:00", "published_display": "10 Jul 2026 20:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology (NXL) Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Stage Continues", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxOXzFwRVlWUHRyNFRTQWdDZ0EwQ1RaNHNVU2NJdFhxWDg0TmJ2VkV4cmJVVHRIQm9fX244VDAza2xxeXNkZ2ZGOVA0V0h3S2k4aTFJX0lzbDYtMy1DWlRYM3dBdEctM2VUTk9obkdSMzRpRGdpR2wtZDcxS0pNX0RpQ0Y2dzgtQlhCYmg4dWVUMmtaUG5XYXh4SDBGOWhYQVYxRVRVS2NJbWh5MlJqMDJYX1JUUG0tZldCd0tRTXZXX3dJYzkxNzhBbzFBSm9nV1JOM3d3Wl9jYw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-07T23:30:05+00:00", "published_display": "07 Jul 2026 23:30", "sentiment": "negative", "sentiment_pct": 15, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to book forward of Nexalin Technology, Inc. \u2013 NASDAQ:NXL", "summary": "", "url": "https://news.google.com/rss/articles/CBMimwFBVV95cUxPenpranR3cWdyOFhQVkNhaUhrcnVzSjg4Tkp2NlAzcE5vdExqNk9PVW1SMVg5endoTzJCMkRyX2VhOFlfYnh1RWJ0MV9pMzdrd0w2TW50VGlVcENzMmFCWEVYN3JGZ3N3Z1BEMGthWWNNS29QTERJRUhHaUVHbHZXMl81Zjg5U21zb3ZtNFBMTUNKX2tvYzRnZXNqYw?oc=5", "source_name": "TradingView", "published_at": "2026-07-05T11:32:53+00:00", "published_display": "05 Jul 2026 11:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces that the Investigator of Its Brazilian Clinical Trial Received the Young Researcher Award at BRAIN 2026 for Research Evaluating the Company\u2019s Proprietary DIFS\u2122 Platform", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nexalin-technology-announces-investigator-brazilian-123000212.html", "source_name": "GlobeNewswire", "published_at": "2026-06-23T12:30:00+00:00", "published_display": "23 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Brazil sleep trial earns award at brain congress", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQNjVkaEhvdVpDT0dLNFRRYmMtbXNmNVFzblVIc0hkRGZodWN2Ny1mMGNGLVFDSnhMb2V2RkI0VTZKU09pZE9NRHlpRHJuLVE1U0o0bjZDVDF3aldWaF9MeXdtSnVfZFdLWlhiang4VmFRVWVtMkhFUl85TGZDWG5jOTBKYWwtWEdmc0o4YmdOUmNFN1doQjJMSkV2Y05PWXZHUHJTTS1Lb3FjeEY5LThrUGhOM3J2WjFyeWQxeVZB?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology, Inc. Financial Disclosures & SEC Filings", "summary": "", "url": "https://news.google.com/rss/articles/CBMiaEFVX3lxTE5aWlFjTF9DMXFsc29weVZDWWxHLU95TElxbVFpTmhGemc4MXhRbE11SUEwSVpILUs2TjdNZm9hcGJCMm5wZ2tZLTVnLXNLZjNadWw0WWxfTnc3Znh2T0FhQkFlQzlUNnVv?oc=5", "source_name": "TradingView", "published_at": "2026-06-21T06:39:02+00:00", "published_display": "21 Jun 2026 06:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology (NXL) overhauls bylaws, lowers quorum and adds exclusive forum rules", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxNLUc2RVo5TnRyZk5rbTFwOHZCelpkMFhzSXZ0YjhxcXptWnNLTWtNdzUtRXJCTWNOMktfXy03U3dRRFpjSWJZaVdkMVg3eHBKSF9tWnJ2MmhXVGdkRUczNzQzNnhHblo5WmhZY1JfdjVPMjQ0WWJxMnh0R3lBMWJXcDFKZFlLOGZQWXA4NjFhUEk1R3o2YURXeTVoU1Bmb2oxSzNlbm5HWVlNZXF1RXIw?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces Two Clinical Abstracts Accepted for Presentation at the 2026 NYC Neuromodulation Conference Highlighting Preliminary Clinical Results Across Anxiety, Depression, Insomnia and Quality of Life", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/nexalin-technology-announces-two-clinical-131500210.html", "source_name": "GlobeNewswire", "published_at": "2026-06-16T13:15:00+00:00", "published_display": "16 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Study Shows Strong Anxiety and Depression Response in Brazil Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-study-shows-strong-anxiety-134705543.html", "source_name": "MT Newswires", "published_at": "2026-06-10T13:47:05+00:00", "published_display": "10 Jun 2026 13:47", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Reports Compelling Clinical Trial Results in Brazil to Support Product Launch. Trial Demonstrates 77.8% Anxiety Response Rate and Durable Benefits Across Depression, Insomnia and Quality of Life as Company Advances Brazilian Sales Plan.", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-reports-compelling-clinical-131500924.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T13:15:00+00:00", "published_display": "10 Jun 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EXCLUSIVE: Nexalin Brazil Trial Shows Benefits Across Anxiety, Sleep And Quality Of Life", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/exclusive-nexalin-brazil-trial-shows-130109302.html", "source_name": "Benzinga", "published_at": "2026-06-10T13:01:09+00:00", "published_display": "10 Jun 2026 13:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Announces Issuance of U.S. Patent Covering Dynamic Frequency Stimulation for Anxiety, Depression and Insomnia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-announces-issuance-u-140000209.html", "source_name": "GlobeNewswire", "published_at": "2026-06-04T14:00:00+00:00", "published_display": "04 Jun 2026 14:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology Secures Key Neurostimulation Legislative Provision & Commends U.S. House-Passed Report Language Expanding Non-Invasive Deep Brain Neurostimulation Research at the Department of Veterans Affairs for Traumatic Brain Injury", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-technology-secures-key-neurostimulation-123000111.html", "source_name": "GlobeNewswire", "published_at": "2026-05-21T12:30:00+00:00", "published_display": "21 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Acquires PONM to Expand AI Health Platform", "summary": "", "url": "https://news.google.com/rss/articles/CBMi0gFBVV95cUxNUjdsUUp5TTU2NFprUi1MbEljRlhNLUZfVHNUMTJubzA4WjRiRlNnaTJDTmRZVzRpZk5GRjVrZXIwWjJleGFQRGVmSThVUFE1OHRTREUzUXBMRl9ieG9mdGRzazNKNHNZVDVxOURrWmpjdnYtQVpQU0NFNWUzMHdscTJqR2dMWlBVcFZjbWRDbUFZYXFSU1FLU3RaSHhZc1g0cVRvbkRJbWgwOXNFWWtYd3F4LUpsUThHbE41Mkx3ai1BZ2E5N1ktR3J2UFdCQXY3X3c?oc=5", "source_name": "The Globe and Mail", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Acquires AI-Integrated Digital Health Platform Behind HALO\u2122 Clarity and Nexalin NeuroCare\u2122 Ahead of Planned FDA Pivotal Trial", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-acquires-ai-integrated-digital-123000796.html", "source_name": "GlobeNewswire", "published_at": "2026-05-19T12:30:00+00:00", "published_display": "19 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Acquires PONM for $1.3 Million in Stock, Adds 24-Month GLV Collaboration", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNRzJYMFUxWVhFc1lPMzdXTy1OU05YYjR5NVduWTBlMWZqN1h0SThKTHIwb3hrOEdPdFg4anVjanctalFMRXl2aUNyaUJ0Qy1xYmNCUkxNYXd0ODNRMDQ4MHZja0doVnVYWHd6Y3pIODlzMzdwcnRJZkpVQWRpQXRGR2Izc2FCUlZTUGY2dHVVTVRNdWozb0QyN1p2TXVpc1QtQ3lyRVNyLWlhazc0c0RPZVZLSlo0dFJ1UUxEVkJaVm14VUQxRGFPd0JybmhtQ0ZFbldMZlVOTQ?oc=5", "source_name": "TradingView", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Announces Peer-Reviewed Publication with Neuroimaging Data in Psychotherapy and Psychosomatics Highlighting Brain-Network Effects  and Clinical Improvement in Chronic Insomnia", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/nexalin-announces-peer-reviewed-publication-131500841.html", "source_name": "GlobeNewswire", "published_at": "2026-04-28T13:15:00+00:00", "published_display": "28 Apr 2026 13:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "After FDA and China meetings, Nexalin reshapes Alzheimer\u2019s study", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxPV3hIaXpFbmlsSkcta0tmS2xKRFY1WE1sZTNfMDlUNnlZQklxNGN4Tl8xMGZfZXRTbEpkaDFsUFZFaDVrNWNSZEVMT2hwWWg0bWtxMXVZeklVei1nUTFMTktDdHZIaE91Nld2UGJULURiZVhhbVJxa05ibGRBaG12XzdLeU9ITFA1RUlvWmhDZGFrMzJwY0Y5UUpsS1lGZDlDUGdab1lhSUlYZmNjeVA3MWNxejA?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-15T07:00:00+00:00", "published_display": "15 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Nexalin Technology stock rises after launching AI-powered virtual clinic", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPdHhrZ3RndjdPU3Y5OWFFQmNfUkZXNkNnT1BYaHRzaFQtT3NFcGRQeVRtUGtJZXZORkNNeHU5eElKM09tRW51NDd4dTRVZmJOYXFMVGJoLXc3VVJydXdCN1pCRE5yYi1tMGYtbVdoY2RNbTZrZFJiVUVOOEdodjVvVVRCU2UtbHFMUHBReWM0RVJGb0hDR0Q1Z01sN0U3dzJFVGQySFpnbUdVRUhrWDRNR2VLWlR4TGs5Wm5ma19PbGZoMjNOSnpwdkhOVGVVZw?oc=5", "source_name": "Investing.com", "published_at": "2026-02-05T08:00:00+00:00", "published_display": "05 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Nexalin Technology (NASDAQ:NXL) In A Good Position To Deliver On Growth Plans?", "summary": "", "url": "https://news.google.com/rss/articles/CBMihwFBVV95cUxQR2dnMlhlVWJLZmFKQ0tTRFN2M01saktkUVNlcURYWEhwZldJRllLYVBPcWtKb09UaGVxZGROOXQ5cnhMd0FjcWxwM3J0SHR2LUFzbW9xQlA0b3pybVdxakFIcjljbWNuVTBJa1k1ZjlGdlJ5eXBKWFBGOXcwUlhPb1VhTzF5Vzg?oc=5", "source_name": "Market source", "published_at": "2025-10-10T07:00:00+00:00", "published_display": "10 Oct 2025 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNTWR3bzJReVB0UTNleWx6WDlmRW1rYmpLdkptZHdadzVERk1hTzdEV0M1Z2tuRUx2cldOT2d3WlVDank5Y01EWWFfWXdWNkJFdkNFcnhjMjdCQ1Y2aFBVbndiNXVBY0F5dDRpU2Fla25fVWRTUlNROXFwYXNXT2czUm5Nbl9QUFhFTEhHd1ZKTzJUSzhJWjN6QnNNUEVBTVEyR0l6YkZacUVsdw?oc=5", "source_name": "Market source", "published_at": "2026-06-16T07:00:00+00:00", "published_display": "16 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Diversified Stocks Q1 Results: Benchmarking Stryker (NYSE:SYK)", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wFBVV95cUxNb1NaVXV6UW42emtDUzh5ckhKVjc2X29fSlFRRDVIVnRLWXpoWEYxUnVKNGZuLVN6ZWhxVno1SGluMEdLcmNrOGN1ZjlsWFpVRWxYbW9aYy01VFFpVzlncWtBYzF3YkJfNzhwTi1BcWlpVF9pUTU4QnNGWkJSV3YwRXVCUzk2Z2NUMWFjVkJOV2hSbFRrRnIxSWxNUGRoQmhQeDVBRjhYSnhvMDJqUThjYjBHRjhTRTBDdDZJd1k3LU5DTjU2cUx6TXFNdHhVS1FfdlFmaWZLNk41cFk?oc=5", "source_name": "StockStory", "published_at": "2026-05-05T07:00:00+00:00", "published_display": "05 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 69, "total_relevant": 32, "sentiment_summary": {"positive": 3, "negative": 1, "neutral": 28, "score": 51, "total": 32, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 9.9, "count": 18}, {"event": "earnings", "label": "Earnings", "weight": 6.19, "count": 14}], "positive_events": 3, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 0.46, "latest_week": "2026-07-10", "one_week_move": 27.6, "four_week_move": 6.9, "twelve_week_move": -0.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 0.675157, "market_dynamics_buy_signal": false, "relative_strength": -46.89413, "fair_value_gap": -60.2, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 40.2239, "reaction_label": "Price confirming higher", "reaction_tone": "positive", "market_sentence": "+27.6% over one week, +6.9% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Price moving ahead of tone", "tone": "positive", "classification": "price_leads_news", "summary": "Price is moving more forcefully than the current news tone suggests.", "confidence": 60, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 10}, {"label": "GlobeNewswire", "count": 7}, {"label": "Stock Titan", "count": 4}, {"label": "TradingView", "count": 3}, {"label": "StockStory", "count": 2}, {"label": "dars.gov.et", "count": 1}, {"label": "Donan\u0131mHaber", "count": 1}, {"label": "MT Newswires", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 21}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 18}, {"label": "Earnings", "count": 14}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Price moving ahead of tone", "tone": "positive", "text": "Price is moving more forcefully than the current news tone suggests."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "21", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "+27.6% over one week, +6.9% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Positive", "tone": "positive", "text": "Nexalin Technology (NXL) Surges Over 11% as Shares Test Key Resistance Level - ATR Stop"}], "updated_at": "2026-07-16T10:54:18.370529+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}